Back to explore
EXPRESSION OF CONCERN: The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double‐blinded, placebo‐controlled trial
3 Assessments
3 Serious · 0 Some · 0 No · 0 N/A
| Reviewer | Date | Q1.1Does the study have an associated retraction? | Q1.2Does the study have an associated expression of concern or other relevant post-publication notice? | Q1.3Do other studies by the research team highlight causes for concern? | Q2.2Are there concerns relating to the timing or absence of study registration? | Overall | Actions |
|---|---|---|---|---|---|---|---|
| RV007 Professor of Health Services Research | 30 Oct 2025 | Yes | Yes | Yes | Unclear | Serious concerns | View |
| RV004 Research Assistant | 3 Nov 2025 | No | Yes | Yes | No | Serious concerns | View |
| RV019 Evidence Synthesis Methdos Lead | 8 Mar 2026 | No | Yes | Yes | No | Serious concerns | View |
Publication Details
Journal
Pediatric Allergy and Immunology
Publisher
Wiley
Published
28 Sept 2018
Pages
pp. 834–840
ISSN / eISSN
0905-6157 / 1399-3038